Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS: 176 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
176
Total FAERS Reports
0
Deaths Reported
110
Hospitalizations
176
As Primary/Secondary Suspect
1
Disabilities

First Report: 2003 · Latest Report: 20201101

What Are the Most Common BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS Side Effects?

#1 Most Reported
Nausea
139 reports (79.0%)
#2 Most Reported
Pyrexia
132 reports (75.0%)
#3 Most Reported
Headache
132 reports (75.0%)

All BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Nausea 139 79.0% 0 97
Anaemia 132 75.0% 0 94
Headache 132 75.0% 0 88
Pyrexia 132 75.0% 0 94
Constipation 128 72.7% 0 88
Pain 128 72.7% 0 87
Erythema 127 72.2% 0 88
Female genital tract fistula 127 72.2% 0 88
Oral candidiasis 126 71.6% 0 87
Proctitis 126 71.6% 0 87
Radiculopathy 126 71.6% 0 87
Vaginal flatulence 126 71.6% 0 87
Colitis ulcerative 125 71.0% 0 86
Frequent bowel movements 122 69.3% 0 88
Abdominal pain 121 68.8% 0 88
Colitis 121 68.8% 0 88
Rectal haemorrhage 121 68.8% 0 88
Vaginal discharge 121 68.8% 0 87
Haematochezia 120 68.2% 0 88
Malaise 96 54.6% 0 96

Who Reports BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS Side Effects? Age & Gender Data

Gender: 91.7% female, 8.3% male. Average age: 66.0 years. Most reports from: CA. View detailed demographics →

Is BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS Getting Safer? Reports by Year

YearReportsDeathsHosp.
2003 1 0 0
2013 2 0 1
2014 3 0 0
2015 9 0 4
2016 1 0 0
2017 2 0 1
2018 8 0 7
2019 2 0 0
2020 3 0 0

View full timeline →

What Is BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS Used For?

IndicationReports
Product used for unknown indication 139
Gastric disorder 10

BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs Alternatives: Which Is Safer?

BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BILASTINE BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMATOPROST BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMATOPROST\TIMOLOL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMEKIZUMAB BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMEKIZUMAB-BKZX BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BINIMETINIB BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIOFLAVONOIDS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIOTIN BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIPERIDEN BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIRCH TRITERPENES

Official FDA Label for BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS

Official prescribing information from the FDA-approved drug label.